Oriol Mirallas

1.1k total citations
35 papers, 225 citations indexed

About

Oriol Mirallas is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Oriol Mirallas has authored 35 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Oriol Mirallas's work include Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Oriol Mirallas is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Radiomics and Machine Learning in Medical Imaging (4 papers). Oriol Mirallas collaborates with scholars based in Spain, Palestinian Territory and Argentina. Oriol Mirallas's co-authors include Josep Tabernero, N. Saoudi Gonzalez, Iosune Baraibar, Élena Elez, Rekek Negga, Javier Ros, David García-Illescas, Vanessa A. Fitsanakis, Francesc Salvà and Ramón Grimalt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

Oriol Mirallas

28 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oriol Mirallas Spain 8 98 39 38 33 29 35 225
Meredith S. Brown United States 9 103 1.1× 17 0.4× 171 4.5× 15 0.5× 62 2.1× 22 367
Yifei Liu China 9 18 0.2× 33 0.8× 195 5.1× 9 0.3× 13 0.4× 17 307
Rongxin Chen China 10 57 0.6× 23 0.6× 145 3.8× 26 0.8× 22 0.8× 15 321
Claire E. McCarthy United States 10 96 1.0× 17 0.4× 74 1.9× 5 0.2× 74 2.6× 14 346
Filomena Russo Italy 9 39 0.4× 64 1.6× 81 2.1× 12 0.4× 8 0.3× 22 264
Xiaoni Chen China 9 52 0.5× 114 2.9× 141 3.7× 4 0.1× 17 0.6× 24 343
Bertha Molina Mexico 11 29 0.3× 21 0.5× 175 4.6× 45 1.4× 10 0.3× 37 327
Satoko Shibata Japan 10 44 0.4× 20 0.5× 51 1.3× 16 0.5× 14 0.5× 20 327
Yajun Li China 10 62 0.6× 25 0.6× 127 3.3× 10 0.3× 38 1.3× 29 319
Hadas Bar‐Joseph Israel 10 59 0.6× 20 0.5× 121 3.2× 7 0.2× 10 0.3× 23 427

Countries citing papers authored by Oriol Mirallas

Since Specialization
Citations

This map shows the geographic impact of Oriol Mirallas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Mirallas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Mirallas more than expected).

Fields of papers citing papers by Oriol Mirallas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oriol Mirallas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Mirallas. The network helps show where Oriol Mirallas may publish in the future.

Co-authorship network of co-authors of Oriol Mirallas

This figure shows the co-authorship network connecting the top 25 collaborators of Oriol Mirallas. A scholar is included among the top collaborators of Oriol Mirallas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oriol Mirallas. Oriol Mirallas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mirallas, Oriol, et al.. (2025). Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores. The Lancet Regional Health - Europe. 54. 101317–101317. 1 indexed citations
2.
Mirallas, Oriol, et al.. (2025). Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies. Frontiers in Immunology. 16. 1664443–1664443. 2 indexed citations
3.
Mirallas, Oriol, et al.. (2025). Emerging Immunotherapy Targets in Early Drug Development. International Journal of Molecular Sciences. 26(11). 5394–5394. 3 indexed citations
4.
Mirallas, Oriol, Ana Carolina Ramos Moreno, Cristina Viaplana, et al.. (2025). Ultrasensitive ctDNA profiling to identify long-term survivors in phase I immunotherapy trials.. Journal of Clinical Oncology. 43(16_suppl). 2560–2560.
5.
Toledo, Rodrigo A., Oriol Mirallas, Ana Carolina Ramos Moreno, et al.. (2024). Prognostic and predictive value of ultrasensitive ctDNA monitoring in a metastatic pan-cancer cohort treated with immune checkpoint inhibitors in the context of phase 1 clinical trials.. Journal of Clinical Oncology. 42(16_suppl). 2510–2510. 2 indexed citations
7.
Mirallas, Oriol, Diana Valbuena, Maria Serena Roca, et al.. (2023). 2144P The PRognostic Oncologic Plantology (PROP) website tool predicts 30-day mortality in hospitalized cancer patients on treatment. Annals of Oncology. 34. S1116–S1117. 2 indexed citations
8.
Grau-Béjar, Juan Francisco, et al.. (2023). Advances in immunotherapy for cervical cancer. Therapeutic Advances in Medical Oncology. 15. 2608572–2608572. 18 indexed citations
9.
Arqués, Oriol, Irene Chicote, Lorena Ramírez, et al.. (2023). DPPA3-HIF1α axis controls colorectal cancer chemoresistance by imposing a slow cell-cycle phenotype. Cell Reports. 42(8). 112927–112927. 4 indexed citations
10.
Mirallas, Oriol, Omar Saavedra, María Vieito, et al.. (2023). Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients. Oral Oncology. 140. 106364–106364. 11 indexed citations
12.
Mirallas, Oriol, et al.. (2022). Advances in the systemic treatment of therapeutic approaches in biliary tract cancer. ESMO Open. 7(3). 100503–100503. 14 indexed citations
13.
Mirallas, Oriol, Núria Pardo, Ana Callejo, et al.. (2022). Hepatic Rupture as the Initial Presentation of an EGFR-Mutated Lung Adenocarcinoma: A Case Report. Frontiers in Oncology. 12. 837630–837630.
14.
15.
Cortellini, Alessio, Elisa Roldán, Margarita García, et al.. (2021). 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Annals of Oncology. 32. S1130–S1130. 3 indexed citations
16.
Mirallas, Oriol, David García-Illescas, Núria Rodríguez, et al.. (2021). 1431P Descriptive analysis and prognostic factors of microsatellite instability (MSI) gastric cancer patients (pts) compared to microsatellite stable (MSS) pts in a tertiary hospital. Annals of Oncology. 32. S1070–S1070. 1 indexed citations
17.
Auclin, Édouard, N. Saoudi Gonzalez, Nicolas Epaillard, et al.. (2020). 1713P Active smoking and severity of COVID-19 infection in cancer patients. Annals of Oncology. 31. S1007–S1008. 1 indexed citations
18.
Mirallas, Oriol, et al.. (2020). Paraneoplastic cerebellar degeneration diagnosed by anti-Yo determination in a young woman with early breast cancer. BMJ Case Reports. 13(8). e233863–e233863. 2 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026